Login

Julien Guerrand of TCM Capital and Martin Baumann, Co-Founder of CMCC Global, share insights as hedge fund and capital management leaders. 00:10:00

Share On Facebook Share On Twitter

Julien Guerrand of TCM Capital

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Shield Therapeutics 'delivered an excellent first half' with Accrufer powering ahead in the US - Greg Madison Chief Executive Officer, Shield Therapeutics P
00:10:00
Our goal is to treat cancer as well as inflammatory and autoimmune diseases|Göran Forsberg,CEO,Cantargia
00:10:00
Pyrum Innovations: Transforming Waste into Valuable Resources for the Future | Pascal Klein, CEO , Pyrum Innovations AG.
00:10:00
CEO and Founder of Aritzia Shares His Journey with Bill Good | Brian Hill, CEO, Aritzia.
00:10:00
Simplifying and Enhancing Your 401(k) Experience with EVOadvisers | Dave O'Brien , Founder, EVOadvisers.
00:10:00
Desktop Metal CEO Ric Fulop Discusses Additive Manufacturing Trends at CastExpo 2022 | Ric Fulop - CEO of Desktop Metal
00:10:00
Works with young founders solving high-impact problems|Alex Fiance,Co-Founder & Co-CEO,Kairos HQ
00:10:00
Challenges and Opportunities in Commercial Real Estate | Drew McKnight, Co-CEO, Fortress Investment Group.
00:10:00
Challenges and Optimism in Underfunded Exploration
00:10:00
Exploring the benefits and risks of owner-financing in real estate transactions.
00:10:00
Introducing Bast Gate's New Wireless Sensors: Simplified Setup and Customizable Solutions
00:10:00
Halfway Through Middlemarch: A Check-In on Characters and Plot

© 2017 - Neuhu+